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Human pregnancy poses a fundamental immunological problem because the placenta and fetus are genetically different from
the host mother. Classical transplantation theory has not provided a plausible solution to this problem. Study of naturally
occurring allogeneic chimeras in the colonial marine invertebrate, Botryllus schlosseri, has yielded fresh insight into the primitive
development of allorecognition, especially regarding the role of natural killer (NK) cells. Uterine NK cells have a unique phenotype
that appears to parallel aspects of the NK-like cells in the allorecognition system of B. schlosseri. Most notably, both cell types
recognize and reject “missing self” and both are involved in the generation of a common vascular system between two individuals.
Chimeric combination in B. schlosseri results in vascular fusion between two individual colonies; uterine NK cells appear essential
to the establishment of adequate maternal-fetal circulation. Since human uterine NK cells appear to de-emphasize primary
immunological function, it is proposed that they may share the same evolutionary roots as the B. schlosseri allorecognition system
rather than a primary origin in immunity.
Copyright © 2008 Amy Lightner et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. THE HUMANMATERNAL-FETAL RELATIONSHIP
Human pregnancy poses a fundamental immunological pro-
blem because the placenta and fetus are genetically different
than the host mother. In 1953, Sir Peter Medawar posited
the fetus as a successful solid organ transplant, initiating a
wave of research that attempted to explain fetal implantation
in terms of classical transplantation immunology [1]. The
mediators of the adaptive immune system are thought to be
responsible for transplant rejection. High intrinsic allogeneic
interactions of CD8+ T cells with foreign major histocom-
patibility complex (MHC) class I molecules are considered
to be the major mediator, but minor histocompatibility
antigens, CD4 T cells, and specific antibodies also play a
significant role. Accordingly, many have studied fetal survival
in the context of escape from the maternal adaptive immune
system via anatomical separation, antigenic immaturity of
the fetus, and/or immunological inertness of the mother.
However, mother and fetus are not truly anatomically sepa-
rate because placental tissue, derived from fetal trophoblasts,
invades deep into maternal uterine myometrium along
spiral arteries, replacing maternal arterial endothelium. This
allows for the exchange of cellular and noncellular material
between mother and fetus. The presence of fetal blood cells,
leukocytes, and trophoblast cells in the maternal circulation
contradicts a role for the placenta as an effective immuno-
logic barrier [2]. In addition, mothers do mount an immune
response to paternal antigens and, not infrequently, possess
specific antibodies or cytotoxic T cells against paternal
MHC molecules. The presence of this response has been
shown to have no effect on pregnancy outcome [2–4], an
observation hypothesized in the past to be related to the
presence of paternal-antigen specific maternal regulatory T-
cells, of blocking antibodies that protect the fetus, and/or
of immunosuppressive plasma proteins [2–6]. It is also
doubtful that the uterus is an immunologically privileged
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site, because, unlike the brain or testes, it is endowed with
a well-developed lymph drainage system [3]. Finally, while
patients with autoimmune diseases provide ample evidence
that there are maternal immunomodulatory changes during
gestation, maternal immunity can certainly still mount a
successful adaptive response against nonself.
Colonial ascidians, a class of marine invertebrates com-
monly known as sea squirts or tunicates, may offer a unique
perspective on the maternal-fetal relationship. Like mother
and fetus, colonial ascidians experience a natural exchange of
allogeneic tissue. Colonies that are successful in this exchange
somehow avoid mutual rejection and reap the benefits of
chimeric life. This phylogenetically ancient species manages
this balancing act without benefit of an adaptive immune
system (which first evolved in cartilaginous fish) [4]. Study
of the immunological mediators for this system of natural
allorecognition may reveal the evolutionary precursor to
modern mechanisms for the human parallel of colonial life:
the maternal-fetal relationship. The colonial ascidian, B.
schlosseri, is interesting for three reasons: (1) its colonial
chimerism has been extensively studied, (2) it appears not
to possess an adaptive immune system, and (3) it is of the
urochordate subphylum, a group of chordates thought to lie
on the evolutionary line leading directly to vertebrates.
2. BOTRYLLUS SCHLOSSERI
Recent reviews have summarized the life cycle and allorecog-
nition of B. schlosseri in detail, but a brief summary is
presented here [5, 6]. B. schlosseri, commonly called the
star ascidian or golden star tunicate, is native to Europe, but
has spread to coastlines around North America, Asia, and
Australasia. Each individual colony member (zooid) has its
ventral side attached to a substrate, upon which the colony
grows laterally, while the free dorsal end has two openings,
the buccal and atrial siphons (Figure 1). Zooids measure 1–
1.5 millimeters in length. They are usually grouped together
into star-shaped clusters or systems of 3–12 members, with
the atrial siphons of all individuals opening into a common
chamber in the cluster’s center. Colonies consist of a number
of clusters embedded in a common gelatinous matrix,
the tunic. The Botryllus colony has the potential to grow
quite large and may be comprised of up to a thousand
individuals [7]. Zooid propagation occurs through asexual
reproduction, so all zooids within an individual colony are
genetically identical. A common vascular system connects
each zooid cluster and terminates in peripheral sacs called
ampullae that are not only important for colony adhesion
to substrate, but also allow for intercellular contact and
exchange among zooids. When the peripheral ampullae of
different colonies come into contact, they either anastomose
and remodel their vessels to form a shared vasculature
under a common tunic [8], or develop inflammatory lesions,
indicating a site of rejection (Figure 2) [9, 10].
This natural chimerism is mediated by an allorecognition
system, primarily controlled by a single, highly polymorphic
locus, the fusibility/histocompatibility locus (Fu/HC) that
contains up to several hundred codominantly expressed
alleles [11, 12]. B. schlosseri allograft reactions differ from
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Figure 1: Botryllus schlosseri colony formation. The B. schlosseri
individual is called a zooid. It attaches to the substrate that it will
grow on by one end. Its free end has two openings or siphons. The
zooid reproduces asexually and groups of 3–12 zooids will group
together to form a cluster or system, with the free end of each zooid
dumping into a central chamber. Clusters, in turn, join to form the
B. schlosseri colony. All clusters in a colony are housed in a common
tunic and share a common vasculature. Vessels in a colony terminate
in peripheral ampullae that, while covered in the tunic, present sites
of colony-to-colony interactions.
MHC-dependent vertebrate graft rejection. Whereas mam-
malian solid organ transplant rejection is thought to rely on
host T-cell engagement with foreign MHC molecules (non-
self), B. schlosseri rejection is based on failure to recognize
self as encoded by the Fu/HC locus. Rejection occurs only
when no Fu/HC allele is shared between the two individual
colonies. Fusion via a shared vasculature is permitted when
at least one Fu/HC allele is shared. In contrast, vertebrate
graft rejection occurs if either MHC haplotype differs. Lastly,
and unlike vertebrate MHC molecules, there is no evidence
that the Fu/HC system functions in antigen presentation,
although it may encode genes involved in innate immunity,
such as complement and pattern recognition receptors [13,
14].
B. schlosseri colony fusion in the presence of acceptable
allorecognition may have several advantages. Larger size may
aid in the control of a long-term feeding substrate and may
limit inter-specific competition. In fact, the respiration rate
of individual zooids decreases as colony size increases [15]. It
has been proposed that environmental conditions (primarily
water flow and food supply) dictate the number of zooids
per generation, the number of coexisting generations in a
colony [16], and the rate of colony resorption (see below).
While it is still unclear if colony forming is a true survival
technique, it stands to reason that colony fusion shifts the
unit upon which natural selection acts from the individual’s
genotype to that of the fused colony. The high degree of
somatic “heterozygosity” in a multichimera may protect it
from hierarchal somatic resorption and thereby create the
best somatic “container” for the reproduction of its gametes.
Amy Lightner et al. 3
2 colonies attempt fusion at
ampullae
Fusion
Resorption of one colony
Necrosis of
one colony
Rejection
Cytotoxic
lesions
Repel
Colony re-growth with
parasitism by somatic
and germ cells
Figure 2: Botryllus schlosseri colony interactions. In the wild, colonies of B. schlosseri can become quite large, and genetic analyses reveal
these colonies to be multichimeric. Interactions between genetically distinct colonies are governed by an allorecognition system controlled by
the fusibility/histocompatibility locus (Fu/HC). When genetically distinct colonies contact one another, they will anastamose if one or both
Fu/HC loci are recognized as self. Fusion involves the creation of a shared vasculature and common tunic. If neither Fu/HC loci are shared,
rejection will occur and inflammatory lesions will develop at sites of contact. One colony will be largely resorbed after acceptable recognition
and successful colony fusion, although some germ and somatic cells of the resorbed individual will persist in the survivor, creating a parasitic
relationship.
Whereas the formation of multichimeras seems to be
preferred in nature, as evidenced by the preference of larvae
to settle in aggregates of kin colonies [13] and to co-
settle with parental colonies [14], phenotypic resorption
of individual colonies occurs in the majority of typically
bichimeric animals that thrive in the laboratory setting.
In most of these bichimeric colonies, this resorption after
initial fusion follows a strict genetic hierarchy. (if colony
A resorbs colony B and colony B resorbs colony C, then
colony A will always resorb colony C.) Heterozygotes at the
Fu/HC locus are always dominant in that they always resorb
homozygotes [17]. Two additional genes, referred to as the
resorption/histocompatibility (Re/HC) loci, also determine
the hierarchy of the resorption reaction [18]. These genes
are not linked to the Fu/HC locus and appear to sort
independently.
To understand the molecular basis of allorecognition,
chimeras were designed from two colonies, each heterozy-
gous at the Fu/HC locus, and sharing one allele [19]. These
investigations demonstrated that the mediators and effectors
of histoincompatibility circulate throughout the common
vascular system of fused colonies and that blood components
of even the resorbed genotype remain following colony
resorption. In B. schlosseri, hemocytes differentiate along
two defined pathways, becoming either (1) phagocytes that
are macrophage—like in their immunostaining characteris-
tics or (2) cytotoxic cells, including hyaline amebocytes [20]
and morula cells [21, 22]. Of these cell types, the morula
cells appear to be the major immunomodulatory hemocytes
in ascidians as they alone display significant changes in
cytokine (IL-1α and TNF-α) secretion upon immunostim-
ulation [23]. Morula cells are also the most viable candidate
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mediators of the alloimmune-mediated resorption [22, 24].
These hemocyte-derived ascidian blood cells are capable of
cytotoxic activity, they proliferate in response to T-cell and
B-cell mitogens, and they accumulate at the ampullae during
rejection reactions [25]. Ascidian blood cells and human
lymphocytes share common immunoglobulin superfamily
proteins and a highly polymorphic disulfide linked, mem-
brane bound heterodimer that may be a precursor to the
MHC products [26, 27].
3. CELLULAR PARASITISM
Several studies have demonstrated that after allogenic fusion
and subsequent colony resorption, germ and somatic stem
cells of the resorbed partner can survive and replicate within
the other partner’s soma and/or gonads (Figure 2) [28].
Thus, the initial fusion/resorption reaction may actually
result in somatic or germ cell parasitism at the cellular
level [29]. However, if all individuals could fuse, one super-
competitor genotype could dominate and homogenize the
genome of the entire species [30]. Therefore, while the initial
fusion/rejection self-recognition reaction likely evolved to
facilitate competition among closely related kin, the rejection
prevents one dominant genotype from homogenizing the
genotype of the entire species through germ-cell parasitism,
with the benefit of preserving genetic diversity.
In addition, it appears that somatic and germ cell
resorption events are independent of one another [31].
The genotype selected somatically may not be the one
selected gametically. The apparent somatic “winner” by
gross resorption could turn out to be the gametic “loser”
if all of its germ cells are colonized and parasitized by
the resorbed individual. In fact, both types of cellular
parasitism seem to represent independent stem cell lineages
existing simultaneously [14]. The retention of stem cells
from seemingly resorbed individuals allows the colony to
be phenotypically plastic in response to its environment.
Indeed, evidence has shown that environmental changes can
alter the colony phenotype [9].
4. B. SCHLOSSERI—THE EVOLUTIONARY LINK
Based on the chordate characteristics of its larva, the ascid-
ians appear to be among our closest invertebrate relatives
[32]. If B. schlosseri shares a common invertebrate ancestor
with humans, it must sit at a critical point in vertebrate evo-
lution, just before the development of the adaptive immune
system. There are, in fact, examples of invertebrate species,
such as the marine organism Hydractinia, that predate B.
schlosseri by several hundred million years, but exhibit a
highly specific allorecognition system [33]. Recognition in
these organisms, however, appears to occur via interactions
in ectodermal- and/or endodermally-derived cells [33–35].
Natural chimeric relationships, which are integral to
the B. schlosseri life cycle, exist rarely among eutherians—
organisms utilizing a placenta to allow in corpus fetal
development. Examples include spontaneous early fusion
of dyzygotic twins, rare cases of germ cell chimerism, and
proliferation of fetal cells in the maternal blood system after
parturition [36, 37]. One instance of natural chimerism,
however, is remarkably common—the maternal-fetal allo-
graft itself. Evolutionary remnants of an allorecognition
system found in the common ancestor shared by B. schlosseri
and modern eutherians may govern maternal-fetal allogeneic
interactions. For B. schlosseri, a single self-identification
system appears to govern its initial allogeneic interactions.
In higher vertebrates, inhibition of NK cell cytolysis by self-
MHC class I molecules resembles the Fu/HC system of B.
schlosseri in that it is based on the suppression of cytolytic
activity via recognition of self.
5. NK CELLS
It is commonly accepted that NK cells share a developmental
precursor with T lymphocytes [38]. In fact, some believe that
the NK cells, found in all invertebrates, are the evolutionary
precursor to lymphocytes [38, 39]. NK cells are a component
of the innate immune system, thought to be important in
the immune response against viruses and tumors that may
downregulate expression of classical MHC molecules [38–
40]. They are non-T, non-B lymphocytes which do not
require prior exposure to act and do not act by recognition
of nonself. NK cell activation is regulated by a complex
interplay between multiple activating and inhibiting signals
[41]. Inhibitory signals are mainly delivered by the self
MHC class I products normally present on the surface of
nucleated cells. The activating signals may be delivered by
several recognized cell surface receptors present on NK cells,
including CD16, the killer inhibitory receptor (KIR)2DS,
and NKp46 [42, 43]. NK cells kill target cells via discharge
of cytoplasmic granules or by cytokine signaling to nearby
macrophages.
Seventy percent of human endometrial leukocytes during
early pregnancy are large granulated lymphocytes, while 20%
are macrophages, and 10% are T cells. B cells and peripheral
CD16+CD56+NK cells are nearly absent [44]. CD16 is a
transmembrane receptor for immunoglobulin (Ig)G and
CD56 is an Ig family glycoprotein expressed on the surface
of all NK cells. Granulated lymphocytes had been identified
in the endometrium of many species, but they were not
identified as NK cells until intense expression of CD56 was
demonstrated. Note that the CD56 marker is only found in
higher order primates and not found in the species that had
been studied prior to its discovery (e.g., rodent, porcine, and
bovine) [45].
6. UTERINE NK CELLS
In humans, uterine granulated lymphocytes differ
immunophenotypically from peripheral blood NK cells
in that they are CD56bright and CD16−, whereas peripheral
blood NK cells are CD56dim and CD16+ [39, 46]. In
addition, although reverse transcriptase polymerase chain
reaction (RT-PCR) has confirmed that uNK cells express
the same families of inhibitory and activating receptors as
peripheral NK cells, they do so in different proportions, and
with variability among individual women [39, 46, 47].
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Figure 3: The human maternal-fetal interface. Fetal blood enters and exits the placenta via the umbilical cord. Fetal vessels lie at the core of
each placental villae and all villae are lined externally by trophoblast cells. The cells of the inner layer (green) are called villous cytotrophoblast
cells. Those of the outer layer develop from the villous cytotrophoblast through syncytialization and are called syncytiotrophoblast (orange).
Floating villae are completely bathed in maternal blood; anchoring villae traverse the intervening blood-filled space to attach to the
maternal decidua. At the tips of the anchoring villae, a subpopulation of cytotrophoblast cells leaves the villae to invade the maternal
endometrial decidua. Here, these extravillous cytotrophoblast (blue) cells encounter populating maternal immune cells. Some extravillous
cytotrophoblast cells will invade the maternal uterine arteries and become endovascular trophoblast cells (blue). Appropriate vascular
invasion by endovascular trophoblast cells results in remodeling of the uterine vasculature (inset, right) and adequate placental perfusion.
Poor vascular invasion by endovascular trophoblast cells results in limited remodeling of the uterine vasculature (inset, left), a condition
associated with adverse pregnancy outcomes.
Uterine NK cells are only found in the human endome-
trium during the menstrual years, implying an active
role in reproduction. Their population peaks during the
progesterone-dependent secretory phase of the menstrual
cycle. After implantation, they persist in the uterine mucosa,
gathering in high concentrations at the site of placental inva-
sion. Although substantial numbers of CD56+ cells remain
in placental tissue during the third trimester of pregnancy
[48], their number gradually decreases over pregnancy and
they are usually absent in term decidua [39, 49].
The uterine mucosa is the only tissue in the human
body where NK cells of any kind are known to proliferate
and survive in large numbers. In the late secretory phase
and early pregnancy, decidual uNK cells appear localized to
the stratum functionalis, forming aggregates around spiral
arteries and glands [44, 46]. Initially, it was speculated that
this localization was due to the effect of the diffusion of
progesterone from blood into the perivascular tissues, since
large numbers of uNK cells are seen after progesterone
treatment. However, more recent evidence suggests the
perivascular distribution reflects the trafficking of uNK
precursors from the circulation [46, 50].
7. TROPHOBLASTMHCMOLECULES
Placenta and uterine mucosa are the primary tissues of the
maternal/fetal interface. Placental villous syncytiotropho-
blast and extravillous cytotrophoblast cells are the fetal
cells most intimately contacted by maternal cells (Figure 3).
According to mRNA analysis, these cells do not express
normal levels of classical MHC I or MHC II molecules [51,
52]. Instead, the extravillous cytotrophoblast cells express
two nonclassical MHC I molecules, human leukocyte antigen
(HLA)-G and HLA-E, and low levels of the classical MHC
I molecule, HLA-C [53, 54]. When compared to HLA-A
and HLA-B, HLA-C, -E, and -G exhibit much lower surface
expression, fewer alleles, reduced polymorphism at peptide
binding sites, and lower intrinsic reactivity with CD8+
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T-cells [53, 55]. This suggests that the primary function
of trophoblast HLA molecules is something other than the
presentation of foreign peptide to CD8+ T-cells. In addition,
trophoblast MHC products are uniquely resistant to the
strategies that multiple viral pathogens employ to evade
immune detection [53, 56–58], suggesting that these class I
products do not have a primary role in pathogen defense.
Substantial evidence demonstrates that MHC molecules,
including trophoblast MHC products, play a role in the inhi-
bition of NK cell mediated target lysis. Inhibitory receptors
on NK cells include members with immunoglobulin-like
characteristics [leukocyte Ig-like receptors (LIRs) and killer
Ig-like receptors (KIRs)] and heterodimers with characteris-
tics of C-type lectins (CD94/NKGs) [59]. It is now known
that the KIRs recognize the classical MHC products (HLA-
A,-B and -C), and CD94/NKG2 recognizes HLA-E molecules
[46, 60, 61]. The recent discovery of the crystal structure of
HLA-G [62] supports tight binding to LIR1 and LIR2 and
poses a plausible ligand-receptor interaction. Others have
demonstrated interactions between HLA-G and KIR2DL4
as well [63]. Furthermore, treatment of fetal cells with
monoclonal antibodies directed against HLA-G and HLA-
C abolishes their resistance to NK cell mediated lysis [64],
while transfection of HLA-G into NK susceptible cell lines
prevents NK cytolysis [65]. Although HLA-G expression has
been recently described in multiple malignancies and chronic
inflammatory conditions, it is never expressed in significant
amounts in normal tissues other than fetal trophoblasts [66].
8. UNK CELL FUNCTION
The most important role of uNK cells may be the regulation
of fetal implantation and initial establishment of the placenta
through vascular remodeling. During implantation, fetal
trophoblast tissue invades muscular uterine tissues and spiral
arteries, converting the latter into enlarged structures with
limited vascular resistence, poor responsivity to vasoactive
signals, and the capability for high conductance (Figure 3).
These changes are necessary to supply sufficient blood vol-
ume to the fetus. When trophoblast invasion is not sufficient,
fetal circulation is compromised resulting in miscarriage,
idiopathic uterine growth retardation (IUGR), stillbirth, and
pre-eclampsia [55, 66]. In fact, decreased expression of HLA-
G on human extravillous trophoblast is associated with
reductions in placental invasion, shallow placentation, and
development of pre-eclampsia, a maternal disease associated
with impaired placental vascularization and development
[67]. Recognition of trophoblast MHC products by uNK
cells could serve as one trigger for cytokine release to induce
and modulate this vascular remodeling. The repertoire of
cytokines secreted by uNK cells includes VEGF-C, PIGF,
Ang-2, TNF-alpha, IL-10, GM-CSF, IL-1Beta, TGF-Beta1,
CSF-1, LIF, and IFN-gamma [68–71], any or all of which
may help to establish a functionally healthy maternal-fetal
circulation [39, 47]. One cytokine, IFN-gamma, seems to be
particularly involved in the control of trophoblast invasion
and the remodeling of uterine spiral arteries during the first
half of pregnancy. Indeed mice deficient in either uNK cells
or IFN-gamma have implantation site abnormalities and
failure of decidual artery remodeling. They exhibit fetal loss
in the second half of gestation, an overall smaller placental
size, and progressive lesions suggestive of hypertension-
mediated arteriosclerosis in the uterine vessels [72]. These
defects can be reversed by grafting bone marrow from NK
cell competent, but T and B cell immunodeficient, severe
combined immunodeficiency (SCID) mouse donors [73]
or RAG-2-/-IFNgamma-/-mice treated with murine IFN-
gamma [74]
A more precise understanding of the roles of uNK cells in
human pregnancy awaits future study of uNK cell receptor
expression and cytokine release. Studies such as in vitro
trophoblast invasion assays in the presence of Ang-2 [75],
TNF-alpha [76, 77], IFN-gamma [77], and TGF-beta1 [78,
79] have provided insight into the role of cytokine pro-
duction in the control of extravillous trophoblast invasion.
Similar in vivo study of cytokine production and effects
at the maternal-fetal interface is highly complicated due
to the short half life of cytokines, difficulty in staining
for endogenous versus exogenous cytokines, considerable
variation in the microenvironment of the uNK cell, and
obvious ethical considerations.
9. EVOLUTIONARY CONSIDERATIONS
We have presented evidence that mammalian uNK cells
are important for the development of the placenta’s vas-
cular supply: immunotropism appears to both promote
trophoblast invasion and the remodeling of spiral arteries.
Vascular fusion among terminal ampulla after acceptable
Fu/HC-mediated recognition in B. schlosseri chimerae leads
to allogenic interactions reminiscent of those established at
the maternal/fetal interface. Although the morula cells that
mediate the recognition/rejection response of B. schlosseri
can help in the foreign cell recognition that determines the
activity of phagocytic cells [80, 81], they are one of only
3 types of hematocyte-derived cells in ascidians. The latter,
recently-described function is partially redundant to the role
of primary phagocytic cells and may have been secondarily
gained through adaptation. Like human uNK cells, morula
cells are thought to rely largely on the recognition of self
rather than the engagement of nonself ligands. It is from
this comparison that we hypothesize that allorecognition and
innate immunity are largely distinct entities with separate
evolutionary origins.
Evolutionary precursors of fetal trophoblasts may have
expressed trophoblast MHC products to engage uNK cells,
and only later evolved the classical MHC molecules that
participate in immune defense. It is not difficult to imagine
that peripheral NK cells evolved from uNK or a common
precursor cell, possibly in response to viral pathogens not
effectively curtailed by MHC-T-cell-based immunity. One
might then speculate that the intrinsic reactivity existing
between T cells and foreign MHC has its origin in NK cell-
trophoblast MHC allorecognition.
Can a system of allorecognition used in modern sessile
marine invertebrates for promoting survival and reproduc-
tion have given rise to the vertebrate adaptive immune
system? Clearly, given the survival of invertebrates, all of
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whom possess only innate immunity, adaptive immunity is
not essential to survival and proliferation of some species.
Intrinsic allorecognition, while present in both colonial
ascidians and mammals, serves different, but vital, functions
in each case. To further unravel the mystery of the fetal-
maternal relationship, the uNK cell lineage needs to be
traced back in evolution. Much more information will
become available once the genetic analyses of human uNK
cells and the B. schlosseri NK-like cells are performed.
Thus far, multiple analogs and several true homologues
linked to MHC genes, cytokines, signaling proteins, and
adhesion molecules have been found in the genome of B.
schlosseri. Recently, it was shown that monoclonal anti-
bodies directed against human IL-1 and TNF-alpha could
stain a subpopulation of stimulated B. schlosseri blood
cells [23]. However, no classic MHC molecule or HLA-G
homolog has yet been found in the B. schlosseri genome
[14], and few Fu/HC gene products have been identified
[82].
HLA-G-like genes are present in lower primates [83–
85]. In fact, an HLA-G-like product is the only class
I molecule expressed in certain New World Monkeys.
This demonstrates that this molecule can function effec-
tively in innate and adaptive immunity. Further, signifi-
cant polymorphism is detectable in the NK receptor-, T
cell receptor-, and peptide-binding regions of the HLA-
G-like molecules of New World Primates, but not of
Old World Monkeys, suggesting divergent evolution and
divergent functions [84]. The former certainly has primary
immune function and a role in pathogen defense; this is
unlikely to be true for the latter. The presence of tro-
phoblast MHC homologues should be further investigated
in lower mammals and genetic linkage studies should be
performed with the Fu/HC locus to determine a possible
relationship. The most obvious obstacle to finding a true
evolutionary relationship is that homologous molecules
operating in nonidentical systems may have different con-
straints on structural conservation and, thus, may display
distinct patterns of change [30]. Still, whether B. schlosseri
allorecognition eventually proves to be truly homologous
or merely analogous, its use for comparison has resulted
in fresh insight into the governing mechanisms and the
evolutionary origins of the human maternal-fetal relation-
ship.
LIST OF ABBREVIATIONS:
CD: Cluster of differentiation
Fu/HC: Fusibility/histocompatibility
HLA: Human leukocyte antigen
Ig: Immunoglobulin
KIR: Killer immunoglobulin-like receptor
LIR: Leukocyte immunoglobulin-like receptor
MHC: Major histocompatibility complex
NK: Natural killer
Re/HC: Resorption/histocompatibility
RT-PCR: Reverse transcriptase polymerase chain reaction
SCID: Severe combined immunodeficiency
uNK: Uterine natural killer
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